Reviva Pharmaceuticals Holdings, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 11/14/2024 | 3.19 M | $4.59 M | 100.00% | 13.26% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 1.83 M | $2.64 M | 47.63% | 7.63% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 1.52 M | $2.18 M | 49.53% | 6.31% |
| VANGUARD GROUP INC | 11/13/2024 | 1.03 M | $1.48 M | 0.00% | 4.27% |
| WOODLINE PARTNERS LP | 11/14/2024 | 684,805 | $986,119 | -57.01% | 2.85% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2024 | 512,202 | $737,571 | 1.51% | 2.13% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 278,496 | $401,100 | 17.95% | 1.16% |
| COLONY GROUP, LLC | 11/14/2024 | 161,000 | $231,840 | 0.00% | 0.67% |
| POLAR ASSET MANAGEMENT PARTNERS INC. | 11/14/2024 | 154,800 | $222,912 | 0.00% | 0.64% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 104,690 | $150,753 | 100.00% | 0.44% |
| GROUP ONE TRADING, L.P. | 11/14/2024 | 75,573 | $108,825 | 157.12% | 0.31% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 72,800 | $104,832 | -41.90% | 0.30% |
| STATE STREET CORP | 11/14/2024 | 71,400 | $102,816 | 0.00% | 0.30% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 63,169 | $90,963 | 54.03% | 0.26% |
| AVANTAX ADVISORY SERVICES, INC. | 11/13/2024 | 60,000 | $86,400 | 100.00% | 0.25% |
| CITADEL ADVISORS LLC | 11/14/2024 | 60,000 | $86,400 | -43.45% | 0.25% |
| SOUND INCOME STRATEGIES, LLC | 10/10/2024 | 30,000 | $43,200 | 0.00% | 0.12% |
| CITADEL ADVISORS LLC | 11/14/2024 | 24,000 | $34,560 | -42.17% | 0.10% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 21,369 | $30,771 | -31.22% | 0.09% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 19,900 | $28,656 | -44.10% | 0.08% |
| EMC CAPITAL MANAGEMENT | 10/28/2024 | 18,401 | $638,000 | -85.15% | 0.08% |
| VIRTU FINANCIAL LLC | 11/20/2024 | 14,266 | $21,000 | 100.00% | 0.06% |
| TWO SIGMA SECURITIES, LLC | 11/14/2024 | 13,944 | $20,079 | 100.00% | 0.06% |
| CITADEL ADVISORS LLC | 11/14/2024 | 13,508 | $19,452 | 100.00% | 0.06% |
| COMMONWEALTH EQUITY SERVICES, LLC | 10/18/2024 | 12,342 | $18,000 | 100.00% | 0.05% |
| 11/06/2024 | 10,378 | $14,944 | 0.00% | 0.04% | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 11/12/2024 | 9,299 | $13,391 | 0.00% | 0.04% |
| MORGAN STANLEY | 11/14/2024 | 6,120 | $8,813 | -65.86% | 0.03% |
| WOLVERINE ASSET MANAGEMENT LLC | 11/04/2024 | 3,555 | $5,119 | -21.52% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 2,822 | $4,064 | 623.59% | 0.01% |
| UBS GROUP AG | 11/14/2024 | 2,313 | $3,331 | -98.25% | 0.01% |
| GODSEY & GIBB, INC | 10/18/2024 | 1,600 | $2,304 | 100.00% | 0.01% |
| ACTIVEST WEALTH MANAGEMENT | 11/12/2024 | 1,000 | $1,440 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 250 | $360 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 215 | $310 | -94.55% | 0.00% |
| SIMPLEX TRADING, LLC | 11/08/2024 | 0 | $0 | -100.00% | 0.00% |
| SABBY MANAGEMENT, LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| ARCHER INVESTMENT CORP | 11/06/2024 | 0 | $0 | -100.00% | 0.00% |
| PALE FIRE CAPITAL SE | 11/12/2024 | 0 | $0 | -100.00% | 0.00% |
Reviva Pharmaceuticals Holdings, Inc.institutional Ownership - FAQ's
During the previous two years, 38 institutional investors and hedge funds held shares of Reviva Pharmaceuticals Holdings, Inc.. The most heavily invested institutionals were:
ARMISTICE CAPITAL, LLC: 3.19 M
MILLENNIUM MANAGEMENT LLC: 1.83 M
Schonfeld Strategic Advisors LLC: 1.52 M
VANGUARD GROUP INC: 1.03 M
Woodline Partners LP: 684,805
Parkman Healthcare Partners LLC: 512,202
41.39% of Reviva Pharmaceuticals Holdings, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 10.17 M shares in the last 24 months. This purchase volume represents approximately $19.21 M in transactions.